Targeting RNA Exonuclease XRN1 Potentiates Efficacy of Cancer Immunotherapy

Abstract

Targeting XRN1 activates an intracellular innate immune response mediated by RNA-sensing signaling and potentiates cancer immunotherapy efficacy, suggesting inhibition of RNA decay machinery as a novel strategy for cancer treatment.